Symbiotec Pharmalab Discloses 5.44% Promoter Share Pledge To Beacon Trusteeship

11 September 2026

Symbiotec Pharmalab Ltd.

Beacon Trusteeship, non-promoter, 0 votes before/after; 34,93,464 pledged via encumbrance

Recent Events

Symbiotec Pharmalab Recreates Promoter Pledges Covering 12.82% Of Share Capital

Symbiotec Pharmalab Sees Mirae Asset Mutual Fund Acquire 5.44% Stake

Get features of